Gunderson Dettmer advised the underwriters. Arcus Biosciences announced the follow-on public offering of 11,000,000 shares at $27.50 per share with aggregate gross proceeds of approximately $302.5…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now